MSA
EGRX

Mason Street Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Mason Street Advisors’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,324
Closed -$201K – 1321
2020
Q4 		$201K Sell
4,324
-219
-5% -$10.2K ﹤0.01% 1414
2020
Q3 		$193K Buy
4,543
+741
+19% +$32.4K ﹤0.01% 1357
2020
Q2 		$182K Buy
3,802
+278
+8% +$13.9K ﹤0.01% 1361
2020
Q1 		$162K Hold
3,524
– – ﹤0.01% 1326
2019
Q4 		$212K Buy
3,524
+90
+3% +$5.37K ﹤0.01% 1372
2019
Q3 		$194K Sell
3,434
-5
-0.1% -$281 ﹤0.01% 1376
2019
Q2 		$191K Buy
3,439
+130
+4% +$6.78K ﹤0.01% 1375
2019
Q1 		$167K Sell
3,309
-106
-3% -$4.72K ﹤0.01% 1446
2018
Q4 		$138K Buy
3,415
+114
+3% +$5.88K ﹤0.01% 1406
2018
Q3 		$229K Buy
3,301
+898
+37% +$68.1K ﹤0.01% 1342
2018
Q2 		$182K Buy
2,403
+85
+4% +$5.35K ﹤0.01% 1398
2018
Q1 		$122K Buy
2,318
+145
+7% +$8.43K ﹤0.01% 1446
2017
Q4 		$116K Buy
2,173
+13
+0.6% +$723 ﹤0.01% 1444
2017
Q3 		$129K Buy
2,160
+236
+12% +$14.3K ﹤0.01% 1414
2017
Q2 		$152K Buy
1,924
+29
+2% +$2.37K ﹤0.01% 1365
2017
Q1 		$157K Buy
1,895
+175
+10% +$13K ﹤0.01% 1342
2016
Q4 		$136K Buy
1,720
+78
+5% +$5.67K ﹤0.01% 1361
2016
Q3 		$115K Buy
+1,642
New +$91K ﹤0.01% 1355

Other funds holding EGRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SGCIA
Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mason Street Advisors's EGRX Position: Q1 2021 in Review

Mason Street Advisors sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2021, closing a stake of 4,324 shares — an estimated $201K sold.

Mason Street Advisors first reported a position in EGRX in Q3 2016 and held it in 18 quarters. The position peaked at $229K in Q3 2018. 155 funds tracked by Wall St. Rank hold EGRX as of Q1 2021.

  • Mason Street Advisors reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 4,324 Eagle Pharmaceuticals, Inc. shares in Q1 2021, an estimated $201K.
  • Mason Street Advisors first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2016 and held it in 18 quarters.
  • Mason Street Advisors's Eagle Pharmaceuticals, Inc. position peaked at $229K in Q3 2018.
  • 155 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.